163 related articles for article (PubMed ID: 30312223)
1. Predictors of Metastases in Rectal Neuroendocrine Tumors: Results of a National Cohort Study.
Concors SJ; Sinnamon AJ; Folkert IW; Mahmoud NN; Fraker DL; Paulson EC; Roses RE
Dis Colon Rectum; 2018 Dec; 61(12):1372-1379. PubMed ID: 30312223
[TBL] [Abstract][Full Text] [Related]
2. Mesenteric Lymphadenectomy in Well-Differentiated Appendiceal Neuroendocrine Tumors.
Raoof M; Dumitra S; O'Leary MP; Singh G; Fong Y; Lee B
Dis Colon Rectum; 2017 Jul; 60(7):674-681. PubMed ID: 28594716
[TBL] [Abstract][Full Text] [Related]
3. Local Excision Versus Radical Resection for 1- to 2-cm Neuroendocrine Tumors of the Rectum: A National Cancer Database Analysis.
Fields AC; Saadat LV; Scully RE; Davids JS; Goldberg JE; Bleday R; Melnitchouk N
Dis Colon Rectum; 2019 Apr; 62(4):417-421. PubMed ID: 30394988
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
5. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
[TBL] [Abstract][Full Text] [Related]
6. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of atypical endoscopic features in rectal neuroendocrine tumors.
Hyun JH; Lee SD; Youk EG; Lee JB; Lee EJ; Chang HJ; Sohn DK
World J Gastroenterol; 2015 Dec; 21(47):13302-8. PubMed ID: 26715813
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.
Chi Y; Du F; Zhao H; Wang JW; Cai JQ
World J Gastroenterol; 2014 Nov; 20(43):16252-7. PubMed ID: 25473180
[TBL] [Abstract][Full Text] [Related]
9. Predicting Survival and Response to Treatment in Gastroesophageal Neuroendocrine Tumors: An Analysis of the National Cancer Database.
Gray KD; Moore MD; Panjwani S; Elmously A; Afaneh C; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2018 May; 25(5):1418-1424. PubMed ID: 29476295
[TBL] [Abstract][Full Text] [Related]
10. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
[TBL] [Abstract][Full Text] [Related]
11. Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors.
Folkert IW; Sinnamon AJ; Concors SJ; Bennett BJ; Fraker DL; Mahmoud NN; Metz DC; Stashek KM; Roses RE
Ann Surg Oncol; 2020 Mar; 27(3):855-863. PubMed ID: 31701298
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcome of Small, Incidentally Detected Rectal Neuroendocrine Tumors Removed by Simple Excisional Biopsy Compared With the Advanced Endoscopic Resection During Screening Colonoscopy.
Kwak MS; Chung SJ; Yang JI; Im JP; Park MJ; Lee C; Kim JS
Dis Colon Rectum; 2018 Mar; 61(3):338-346. PubMed ID: 29369898
[TBL] [Abstract][Full Text] [Related]
13. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine Tumors in Meckel's Diverticulum: Recommendation for Lymphadenectomy Regardless of Tumor Size Based on the NCDB Experience.
Dogeas E; Magallanes M; Porembka MR; Wang SC; Yopp AC; Polanco PM; Mansour JC; Choti MA; Zeh HJ; Augustine MM
J Gastrointest Surg; 2019 Apr; 23(4):679-685. PubMed ID: 30706377
[TBL] [Abstract][Full Text] [Related]
15. Short- and Long-term Outcomes of Laparoscopic Total Mesenteric Excision for Neuroendocrine Tumors of the Rectum.
Takatsu Y; Fukunaga Y; Nagasaki T; Akiyoshi T; Konishi T; Fujimoto Y; Nagayama S; Ueno M
Dis Colon Rectum; 2017 Mar; 60(3):284-289. PubMed ID: 28177990
[TBL] [Abstract][Full Text] [Related]
16. Well-differentiated rectal neuroendocrine tumors: analysis of histology, including insulinoma-associated protein 1 expression, and biologic behavior, involving a large cohort of 94 cases.
Sappenfield R; Gonzalez IA; Cao D; Chatterjee D
Hum Pathol; 2020 Oct; 104():66-72. PubMed ID: 32763255
[TBL] [Abstract][Full Text] [Related]
17. Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer.
Jäger T; Neureiter D; Urbas R; Klieser E; Hitzl W; Emmanuel K; Dinnewitzer A
Dis Colon Rectum; 2017 Aug; 60(8):815-826. PubMed ID: 28682967
[TBL] [Abstract][Full Text] [Related]
18. A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Russell MC; Cardona K; Sullivan PS; Maithel SK
J Surg Oncol; 2019 Nov; 120(6):932-939. PubMed ID: 31448820
[TBL] [Abstract][Full Text] [Related]
19. [Rectal neuroendocrine tumors: endoscopic therapy].
Eick J; Steinberg J; Schwertner C; Ring W; Scherübl H
Chirurg; 2016 Apr; 87(4):288-91. PubMed ID: 26801755
[TBL] [Abstract][Full Text] [Related]
20. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
